Head-to-Head Comparison
| Criteria | Fadogia Agrestis | Tongkat Ali | Winner |
|---|---|---|---|
| Testosterone Augmentation | Weak -- dose-dependent increases observed in rat models only | Moderate -- potential 15-37% increase in free testosterone in humans | Tongkat Ali |
| Cortisol Regulation | Unknown -- no human data available | Moderate -- approximately 16% reduction in cortisol levels | Tongkat Ali |
| Safety & Toxicity Profile | Weak -- evidence of testicular toxicity at high doses in rats | Moderate -- established safety profile in human clinical trials | Tongkat Ali |
| Clinical Evidence Strength | Weak -- limited exclusively to animal/in vitro studies | Moderate -- growing body of human RCTs and meta-analyses | Tongkat Ali |
| Standardization & Dosing Precision | Unknown -- no standardized human dosing protocols established | Strong -- standardized to 2% eurycomanone at 200-400mg | Tongkat Ali |